The mechanism of placental regulation of epidural-related maternal fever and its application in the differential diagnosis of the causes of labor fever.

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500103525

Enrollment

Unknown

Registered

2025-05-30

Start date

2025-07-01

Completion date

Unknown

Last updated

2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epidural-related maternal fever

Interventions

The presence or absence of fever and the use of epidural labor analgesia were divided into 6 groups:NA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pregnant women > 36 weeks gestation

Exclusion criteria

Exclusion criteria: Hepatitis B patients, AIDS patients, patients with high pregnancy, fetal distress mothers, placenta previa patients and other severely ill mothers.

Design outcomes

Primary

Measure	Time frame
Ratio of IL-6/IL-10 mRNA expression in maternal plasma.;Ratio of maternal placenta-derived IL-6/IL-10 mRNA expression.;Detection of inflammation-related factors in plasma: IL-1, IL-6, IL-4, TNF;	—

Countries

China

Contacts

Public ContactJin Xiaogao

The Second Affiliated Hospital of Guangdong Medical University

jinxiaogao@yeah.net+86 139 0250 1985

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026